Herbert Lepor, MD is a specialist in Urologic Oncology at NYU Langone Health. He has dedicated over four decades to advancing the field of urology, actively treating patients with prostate cancer and conducting critical research. As the Chief of Urology and the Martin Spatz Chair in the Department of Urology at NYU Grossman School of Medicine, he is recognized for pioneering innovations such as the nerve-sparing radical prostatectomy and focal therapy for prostate cancer. He has treated over 5,000 patients, focusing on improving surgical outcomes and preserving quality of life. His groundbreaking work in image-guided diagnostic techniques, including MRI, allows precise treatment decisions for patients with prostate cancer. Lepor has authored numerous publications and presents his findings at academic meetings both nationally and internationally, contributing to the body of knowledge in the management of prostate cancer. He emphasizes the importance of personalized patient care, taking the time to listen to patients and engage them in their treatment decisions. Lepor remains at the forefront of research exploring neuropharmacology and the physiological role of receptors in the prostate, aiming to improve management strategies for benign prostatic hyperplasia (BPH) and related conditions.
NYU Langone Health • New York, NY
Leading the Department of Urology, focusing on innovative care and improving patient outcomes.